Sponsor:
Mayo Clinic
Code:
NCT06880861
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06880861
Start date
Jul 1, 2025
Status verified date
Aug, 2026
Completion date
Sep 30, 2026
Anticipated
Primary completion date
Sep 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Arizona
Recruiting
Scottsdale, Arizona, United States, 85259
Contacts
Principal Investigator:
Diane K. Ehlers, PhD
Sponsor
Mayo Clinic
Last update posted
Aug 4, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-08-04.